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Reactive oxygen and nitrogen species are important microbicidal agents and are also 
involved in lymphocyte unresponsiveness during experimental infections. Many of the 
biological effects attributed to nitric oxide are mediated by peroxynitrites, which induce 
the nitration of immune cells, among others. Our group has demonstrated that nitric 
oxide is involved in the suppressive activity of myeloid-derived suppressor cells in 
Trypanosoma cruzi-infected mice, with a higher number of CD8+ T cells suffering sur-
face-nitration compared to uninfected controls. Studying the functional and phenotypic 
features of peripheral CD8+ T cells from chagasic patients and human cells experimen-
tally infected with T. cruzi, we found that different regulatory mechanisms impaired the 
effector functions of T cytotoxic population from seropositive patients. Peripheral leu-
kocytes from chagasic patients showed increased nitric oxide production concomitant 
with increased tyrosine nitration of CD8+ T cells. Additionally, this cytotoxic population 
exhibited increased apoptotic rate, loss of the TCRζ-chain, and lower levels of CD107a, 
a marker of degranulation. Strikingly, IL-6 stimulation of in vitro-infected peripheral blood 
mononuclear cells obtained from healthy donors, blunted T. cruzi-induced nitration of 
CD3+CD8+ cells, and increased their survival. Furthermore, the treatment of these 
cultures with an IL-6 neutralizing antibody increased the percentage of T. cruzi-induced 
CD8+ T cell nitration and raised the release of nitric oxide. The results suggest that the 
under-responsiveness of cytotoxic T cell population observed in the setting of long-term 
constant activation of the immune system could be reverted by the pleiotropic actions of 
IL-6, since this cytokine improves its survival and effector functions.
Keywords: tyrosine nitration, peroxynitrite, cD39, cD73, oxidative stress, Trypanosoma cruzi infection
inTrODUcTiOn
CD8+ T cells play a critical role in the immunity against intracellular pathogens, including the 
protozoan parasite Trypanosoma cruzi, the causative agent of Chagas cardiomyopathy (1). Chagas 
disease is characterized by two distinct phases: the acute phase, which lasts several weeks and is 
characterized by non-specific symptoms; and the chronic phase, lasting lifelong. The host’s ability to 
control T. cruzi infection is substantial, but not fully effective, since most infected individuals tightly 
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limit parasite numbers but fail to completely clear the infection 
due to diverse and fascinating immune evasion processes (2). 
Indeed, parasite persistence at low levels into target cells is the 
hallmark of the indeterminate or asymptomatic chronic phase 
(3). Up to 40% of infected individuals develop progressive heart 
disease leading to an end-stage dilated cardiomyopathy.
One key defense mechanism against T. cruzi is exerted by 
nitric oxide (NO), which is produced by inducible NO synthase, 
among other enzymes, present in monocytes/macrophages 
and cardiomyocytes (4, 5). The parasite triggers activation of 
macrophage NADPH oxidase, resulting in a continuous pro-
duction of superoxide anion O2
−( )  and also stimulates infected 
macrophages to produce different amounts of NO. Despite its 
importance as a microbicidal agent at high levels, persistent 
low levels of NO have been involved in the establishment and 
maintenance of lymphocyte unresponsiveness in different experi-
mental models of parasite infections (6–8). These mechanisms 
illustrate a clear parasite evasion strategy. Moreover, NO induces 
apoptosis of many different cell types in vitro and in vivo (9, 10). 
We found that IL-6 regulates inflammasome activation and, 
consequently, IL-1β-induced NO production in a murine model 
of T. cruzi infection. The anti-inflammatory action of IL-6 seems 
to be central for controlling local and systemic oxidative stress, 
promoting cellular rescue of apoptosis, and protecting infected 
IL-6-deficient mice against death (unpublished observation). 
This could be a novel mechanism that regulates NO release in the 
setting of T. cruzi infection.
The presence of low levels of NO rapidly initiates a reaction 
with the superoxide anion generating peroxynitrites that induce 
the nitration of surface proteins on T cells (11, 12). It is widely 
accepted that reactive nitrogen species (NO and peroxynitrites) 
contribute to the immunosuppressive attitude of myeloid-derived 
suppressor cells (MDSCs), a heterogeneous cell population 
associated with tumors, infectious, and inflammatory diseases. 
Our group has demonstrated that MDSCs during acute T. cruzi 
experimental infection were able to inhibit T cell proliferation 
in vitro (13). Furthermore, we also observed a higher number of 
splenic CD8+ T cells suffering surface nitration in infected mice 
compared to uninfected controls.
Chronic exposure to antigens may cause functional defects 
in pathogen-specific T cells. It has been reported that individu-
als with more severe clinical disease have a significantly lower 
frequency of T. cruzi-specific CD8+IFNγ+ T cells than subjects 
in the asymptomatic stage of the infection (14). This impairment 
in T. cruzi-specific CD8+ T cell responses was associated with 
an increased frequency of fully differentiated memory cells and 
an increased rate of apoptosis in the total peripheral CD8+ T 
cell population. The results reveal a progressive exhaustion in the 
parasite-specific cytotoxic T cell compartment in patients with 
long-term T. cruzi infection. However, during persistent infec-
tion, the chronic exposure to an inflammatory microenvironment 
may also contribute to the impairment of CD8+ T cell responses, 
resulting in a less efficient control of the pathogen and promoting 
its persistence.
These findings prompted us to investigate the frequency and 
functionality of circulating CD8+ T cells from patients with 
chronic Chagas disease, with particular focus on the molecular 
mechanisms triggered by IL-6 associated with cytotoxicity and 
NO-induced cell death. In agreement with previous reports in 
seropositive patients with Chagas disease, we found a substan-
tial reduction in the total peripheral T cell compartment at 
the expense of CD8+ T cells (14). Additionally, we observed 
increased NO-producing leukocytes concomitant with increased 
nitration of CD8+ T cells and impaired cytotoxic functionality of 
T cells. Strikingly, IL-6 prevented the nitration of CD8+ T cells 
and increased their survival when healthy donor peripheral 
blood mononuclear cells (PBMCs) were infected in vitro. In this 
context, IL-6 led to a decrease in IL-1β levels. The results suggest 
that the under-responsiveness of the whole cytotoxic T cell popu-
lation from chagasic patients could be reverted by the pleiotropic 
actions of IL-6, since this cytokine functions as a survival factor 
for CD8+ cells and improves the cytotoxic T cell functionality 
in the setting of long-term constant activation of the immune 
system.
MaTerials anD MeThODs
ethics statement
Subjects were recruited at the “Hospital Nuestra Señora de la 
Misericordia” (HNSM) from Córdoba-Argentina. All studies 
were conducted according to the principles expressed in the 
Declaration of Helsinki. Signed informed consent was obtained 
from all donors before inclusion in the study. Venous blood 
was drawn from 46 non-chagasic and chagasic subjects (age 
25–60 years) using a protocol that was reviewed and approved 
by the Comité Institucional de Ética de la Investigación en Salud 
del Adulto, Ministerio de Salud de la Provincia de Córdoba (Acta 
number 194/2014, Argentina). T. cruzi infection was determined 
by a combination of indirect hemagglutination (IHA) and 
enzyme-linked immunosorbent assay (ELISA) performed in the 
laboratory of HNSM. Subject positive on these two tests were 
considered infected. Chronic chagasic patients (n =  22) were 
evaluated clinically and by electrocardiogram and chest X-ray. 
The uninfected control group (n = 24) consisted of age-matched 
individuals were serologically negative for T. cruzi. All donors 
with chronic or inflammatory pathology or erythrocyte sedimen-
tation rate >30 mm or white blood cells count <4,000 or >10,000/
mm3 were excluded from the study.
Blood collection
Approximately 15 mL of blood was drawn from each individual 
by venipuncture and placed into heparinized tubes (Vacutainer, 
BD Bioscience). An aliquot of 50  µL of total peripheral blood 
was stained for FACS analysis and subjected to ACK lysing 
buffer to remove erythrocytes. PBMCs were isolated through 
density gradient centrifugation using Ficoll-Hypaque PLUS (GE 
Healthcare Bioscience) and resuspended in RPMI 1640 (Gibco) 
supplemented with 10% heat-inactivated FCS (Natocor).
Ex Vivo Flow cytometry
Peripheral blood was lysed with ACK lysing buffer to remove 
erythrocytes, and 01 × 106 cells were blocked with Fc block and 
stained with anti-human CD3 Alexa 488 or PerCP, anti-human 
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CD4 Alexa 647, anti-human CD8 PECy7, anti-human CD39 
biotin and streptavidin APC, anti-human CD73 PE (eBioscience 
and Biolegend), anti-nitrotyrosine (Sigma-Aldrich), and anti-
rabbit Alexa 647 or CD20 PECy7 (Biolegend). The intracellular 
expression of ζ-chain was analyzed with anti-human TCRζ PE 
antibody (Beckman Coulter). Stained cells were analyzed by flow 
cytometry (FACS Canto II, Becton Dickinson), with cellular 
debris being excluded from the analysis. Data were analyzed 
using the FlowJo software.
cell Viability Measurement
Leukocytes from peripheral blood were stained with anti-human 
CD3 Alexa 488, anti-human CD4 Alexa 647, anti-human CD8 
PECy7 or APCCy7, anti-human CCR7 Alexa 488, anti-human 
CD45RA PECy7, and labeled with 5  µL of Annexin VPE (BD 
Pharmingen) for 15 min on ice. Before acquisition, the cells were 
stained with 7-AAD (BD Bioscience). A minimum of 300,000 
events for each condition were analyzed by flow cytometry. Staining 
of peripheral blood T cells with antibodies to CD45RA and CCR7 
reveals four cells subsets: naïve T cells are CD45RA+CCR7+, 
central memory cells are CD45RA−CCR7+, effector memory 
(EM) cells are CD45RA−CCR7−, and terminally differentiated 
effector memory (EMRA) are CD45RA+CCR7− (15).
To determine Bcl-2 expression, PBMCs stained for CD3 
PerCP, CD8, CD4, CCR7, and CD45RA surface expression were 
permeabilized with FOXP3 staining buffer set (eBioscience) and 
labeled with anti-Bcl-2 rabbit (Cell Signaling) and then with 
anti-rabbit Alexa 488 or anti-rabbit Alexa 647. Stained cells were 
analyzed by flow cytometry.
cD8+ T cell Functionality
Peripheral blood mononuclear cells were cultured with anti-
CD107a PE (Biolegend), monensin, brefeldin A, phorbol 
12-myristate 13-acetate (PMA), and ionomycin (Sigma) for 4 h, 
then stained with anti-IFNγ FITC, anti-TNF APC, and anti-IL-2 
APC-Cy7 (Biolegend or eBioscience), and analyzed by flow 
cytometry.
To evaluate the effect of TCR-dependent activation, PBMCs 
were cultured with anti-CD3 (1 µg/mL) and anti-CD28 (0.5 mg/
mL). After 72 h, PBMCs were cultured with monensin, brefeldin 
A, and anti-CD107a PE for 6 h and then stained with anti-human 
CD8 APCCy7, anti-NT rabbit and anti-rabbit Alexa 647, anti-
IL-2 PECy7, anti-TNF PerCPCy5.5, or anti-IFNγ PerCPCy5.5.
cD8+ T cell exhaustion
Peripheral blood mononuclear cells were cultured with anti-CD3 
(1 µg/mL) and anti-CD28 (0.5 mg/mL). After 72 h, the cells were 
stained with anti-human CD8 APCCy7, anti-Tim3 PerCPCy5.5, 
anti-PD1 PECy7, anti-CTLA4 PE, anti-CCR7 Alexa 488, and 
anti-NT rabbit and anti-rabbit Alexa 647.
Measurement of reactive Oxygen and 
nitrogen species
The nitrite/nitrate content, indicative of NO production, was 
monitored by the Griess reagent assay (16). In 96-well plates, 
plasma samples were mixed with 50  µL of Griess reagent, 
consisting of 1% sulfanilamide in 5% phosphoric acid and 0.1% 
N-(1-napthyl) ethylenediamine dihydrochloride [1:1 ratio (vol/
vol)], and incubated for 10 min. The change in absorbance was 
monitored at 545  nm (standard curve, 0–200  µmol sodium 
nitrite).
The production of ROS and NO was evaluated using the 
molecular probes: H2DCF-DA (10  µM, Invitrogen Inc.) and 
DAF-FM DA (10 µM, Molecular Probes, Inc.), respectively. All 
samples were acquired on a FACS Canto II cytometer and then 
analyzed using the Flow Jo software.
Quantification of cytokines
Plasma samples were analyzed for TNF, IL-6, IL-10, IFNγ, and IL-4 
by using bead-based immunoassays and flow cytometry, accord-
ing to the manufacturer’s instructions (LegendPlex-Biolegend). 
In cultured supernatant, IL-1β levels were measured by Ready-
SET-Go ELISA kit from eBioscience.
culture of PBMcs and Parasites
Vero cell monolayers were infected with trypomastigote forms of 
T. cruzi Tulahuen strain for 3 h and then washed and maintained 
in RPMI (Gibco Invitrogen Corporation) at 37°C in a 5% CO2 
atmosphere. After 7 days, the parasites were collected from the 
supernatant of infected cells and harvested by centrifugation at 
4,400 rpm for 5 min.
Peripheral blood mononuclear cells from non-chagasic 
donors were cultured with T. cruzi Tulahuen trypomastigotes 
(1:1 rate) for 3  h, then the cells were washed and cultured 
with recombinant bioactive IL-6 (20 ng/mL) or with anti-IL-6 
(2 µg/mL) (Biolegend) or anti-IL-6 plus anti-IL-1β (2 µg/mL), 
or maintained in medium alone for 48 h. Then, culture super-
natants were evaluated for IL-1β/NO levels, and the cells were 
analyzed for NT staining or NO production by flow cytometry. 
In addition, peripheral blood from chagasic patients and control 
donors (250 µL) were cultured with 7,500 trypomastigotes with 
or without IL-6 (20 ng/mL) or maintained in medium for 24 h 
and then cells were harvested to evaluate NO and ROS produc-
tion and NT by flow cytometry.
statistical analysis
Statistical analysis was performed with GraphPad Prism 5.0 
software by using parametric or non-parametric paired t test 
according to data distribution. p Values <0.05 were considered 
significant.
resUlTs
chagasic Patients showed a lower 
number of Peripheral Blood cD8+  
T lymphocytes
A total of 46 peripheral blood samples from chagasic and 
non-chagasic donors of both sexes, collected from people liv-
ing in Cordoba (Argentina) were analyzed for T. cruzi-specific 
antibodies by ELISA and IHA (Table 1). The median value for 
anti-T. cruzi antibody titers detected by IHA was 1/256 (local 
FigUre 1 | cytotoxic T lymphocytes from chagasic patients show higher death rate and less Bcl-2 expression. (a) Percentage of viable and 
apoptotic + necrotic CD3+CD8+ from chagasic patients (n = 5) and non-chagasic donors (n = 5) analyzed by Annexin-V and 7AAD staining. (B) Representative 
histogram of Bcl-2 expression in cytotoxic T cells and percentage of T lymphocytes and CD8+ T cells expressing Bcl-2 in chagasic patients (n = 5) and in 
non-chagasic donors (n = 5) (*p < 0.05 and **p < 0.01). (c) Frequency of naïve, central memory (CM), effector memory (EM), and effector memory RA (EMRA) 
gated in viable cells (7AAD−) or dead cells (7AAD+) in CD8+ lymphocytes from seropositive patients (n = 4) (viable naïve vs. dead naïve p = 0.002; viable EM vs. 
dead EM, p = 0.0002). (D) Frequency of naïve, CM, EM, and EMRA gated in Bcl-2+ or Bcl-2− in CD8+ cells from chagasic patients (n = 4) (naïve Bcl-2+ vs. naïve 
Bcl-2−, p = 0.0123).
TaBle 2 | Peripheral blood lymphocyte subpopulations.
non-chagasic  
donors (n = 15)
chagasic  
patients (n = 8)
p-Value
lymphocyte subsets in peripheral blood
CD3+ (%) 58.6 ± 3.9 43.2 ± 5.3 p = 0.03*
CD3+/μL  
(absolute number)
1,139 ± 102 754 ± 135 p = 0.04*
CD3+CD4+ (%) 58.7 ± 3.7 57.6 ± 2.0 p = 0.84
CD3+CD4+/μL  
(absolute number)
600 ± 72 535 ± 65 p = 0.59
CD3+CD8+ (%) 39.9 ± 3.5 30.74 ± 2.2 p = 0.04*
CD3+CD8+/μL  
(absolute number)
381 ± 56 193 ± 32 p = 0.049*
CD20+ (%) 14.1 ± 1.5 12.3 ± 1.6 p = 0.44
CD20+/μL  
(absolute number)
305 ± 40 218 ± 32 p = 0.16
Values are expressed as mean value ± SE.
*p < 0.05, significant.
TaBle 1 | Description of subject groups.
non-chagasic  
donors (n = 24)
chagasic  
patients (n = 22)
age (years old)
Range 25–60 25–48
Median 30 32
gender
Female n = 16 n = 17
Male n = 8 n = 5
clinical evaluation
Electrocardiographic changes NE n = 1a
Echocardiographic changes NE n = 1b
Chest X-rays abnormalities NE n = 0
aComplete right-bundle branch block and left anterior hemiblock.
bLeft atrial enlargement.
NE, not evaluated.
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cutoff titer 1/32). Only one patient showed a complete right-
bundle branch block, left anterior hemiblock, and left atrial 
enlargement, clinical features of chagasic heart disease. Cordoba 
is considered by the Argentine Ministry of Health to be at high 
risk for vector transmission, since there is a reemergence of this 
infection route by an increase in house infestation and a high 
seroprevalence in vulnerable groups (17).
FigUre 2 | chagasic patients exhibit a higher number and frequency of nitric oxide-producing leukocytes. (a) Percentage and (B) absolute number of 
nitric oxide (NO)-producing leukocytes from chagasic patients (n = 15) and non-chagasic donors (n = 19). (c) Mean fluorescence intensity of NO in leukocytes from 
chagasic patients (n = 11) and non-chagasic donors (n = 20). (D) Serum nitric oxide levels in seropositive patients (n = 14) and seronegative donors (n = 14) 
(*p < 0.05 and **p < 0.01).
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Seropositive patients with Chagas disease showed a dimin-
ished percentage and absolute number of total peripheral T lym-
phocytes (CD3+) compared to seronegative donors. Although 
no differences were observed between non-chagasic and chagasic 
patients in the percentage and absolute number of T helper cells 
(CD3+CD4+), the percentage and absolute number of cytotoxic 
T cells (CD3+CD8+) were significantly lower in seropositive 
than in seronegative patients (Table 2).
No differences were observed in the percentage and absolute 
number of B lymphocytes (CD20+) between the analyzed groups 
(Table 2).
cytotoxic T lymphocytes from chagasic 
Patients showed higher cell Death and 
less Bcl-2 expression
Through Annexin V and 7-AAD staining, we found that fresh 
explanted CD8+ T lymphocytes from chagasic patients showed 
a diminished percentage of viable cells, and concomitantly, a 
higher rate of apoptotic and necrotic cells compared to non-
chagasic donors (Figure 1A). In agreement, the expression of the 
anti-apoptotic protein Bcl-2 was significantly higher in cytotoxic 
lymphocytes from non-chagasic than from chagasic patients 
(Figure 1B). Among cytotoxic T cells from Chagas patients, naïve 
CD8 T cells were the phenotype most susceptible to die (viable 
cells vs. dead cells: 24.53 ± 6.11 vs. 62.48 ± 3.95%). In contrast, 
EM cytotoxic T cells showed significantly increased survival 
rate (viable cells vs. dead cells: 49.75 ± 3.06 vs. 19.48 ± 2.45%) 
(Figure 1C). In accordance, the frequency of naïve cells negative 
for intracellular Bcl-2 expression was significantly lower than 
naïve cells positive for the expression of this anti-apoptotic pro-
tein (Bcl-2+ vs. Bcl-2−: 9.95 ± 0.87 vs. 17.67 ± 2.07) (Figure 1D). 
Furthermore, the percentage of EM CD8 T cells was higher in 
Chagas subjects in comparison with seronegative donors (Figure 
S1 in Supplementary Material).
nitric Oxide-Producing leukocytes Were 
increased in chagasic Patients
Seropositive patients showed an increased percentage and 
absolute number of NO-producing leukocytes (Figures  2A,B), 
with higher production of NO per leukocyte (Figure  2C), but 
no significant differences were detected in levels of plasma NO 
in comparison with seronegative subjects (Figure  2D). The 
infection of peripheral blood from seronegative and seropositive 
patients with trypomastigotes (Tulahuen strain) significantly 
increased the percentage of NO- and ROS-producing leukocytes 
(Figure S2 in Supplementary Material).
cD8+ T lymphocytes from chagasic 
Patients exhibited high levels of nitrated 
Tyrosine residues
Non-chagasic individuals exhibited significantly lower tyrosine 
nitration (NT) of leukocytes, lymphocytes, and T cells than cha-
gasic patients (Figure 3A). In particular, chagasic patients showed 
FigUre 3 | cD8+ T lymphocytes from chagasic patients present high tyrosine nitration. (a) Percentage of nitrated (NT) leukocytes, lymphocytes, and T 
cells from seropositive patients (n = 6) and seronegative donors (n = 6). (B) Representative dot plot of tyrosine nitration on cytotoxic T-cell surface and percentage of 
NT+CD3+CD8+ and NT+CD3+CD8− lymphocytes from chagasic patients (n = 6) and non-chagasic donors (n = 6). (c) Percentage of NT+CD3+CD8+ and 
NT+CD3+CD8− and mean fluorescence intensity of NT in CD3+CD8+ and CD3+CD8− cells from chagasic patients (n = 5) (*p < 0.05, **p < 0.01, and 
***p < 0.001). (D) Frequency of naïve, central memory, effector memory (EM), and effector memory RA gated in NT+ or NT− in CD8+ cells from chagasic patients 
(n = 4) (naïve NT+ vs. naïve NT−, p < 0.0001; EM NT+ vs. EM NT−, p < 0.0001).
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more NT+CD8+ T lymphocytes compared to non- chagasic 
donors (Figure 3B). Although nitration also increased in CD8− 
T cell population from seropositive patients, a main effect was 
observed in CD8+ T lymphocytes compared to CD8− T cells in 
this group of patients (Figure 3C). Among NT+ cytotoxic cells 
from Chagas patients, we have identified naïve cells as the main 
subpopulation that undergoes tyrosine nitration (NT+ vs. NT− 
81.45 ± 3.00 vs. 6.50 ± 1.61%). On the contrary, the majority of 
NT− cells were EM CD8+ T cells (NT+ vs. NT− 5.73 ± 1.22 vs. 
66.33 ± 4.46%) (Figure 3D).
cytotoxic T cells from chagas Patients 
Were less Functional
Even though CD4+ T lymphocytes from seropositive and seron-
egative individuals showed similar levels of expression of the 
TCRζ chain, the cytotoxic T cells exhibited a diminished amount 
of TCRζ in chagasic patients, as compared to non-chagasic 
donors (Figure 4A). In line with these observations, CD8 T cell 
population from seropositive patients showed lower frequency of 
CD107a+ cells, as well as IFNγ, TNF, and IL-2-producing cells 
after stimulation with PMA/Ionomycin (unspecific stimuli) in 
comparison with the same population from seronegative donors 
(Figure 4B). Furthermore, after anti-CD3/anti-CD28 stimulation 
(via TCR), the percentage of CD8+ T cells from Chagas patients 
positive for CD107a, IFNγ, TNF, and IL-2 was significantly 
diminished in NT+ cells compared to NT− cells (Figure 4C). The 
same behavior was observed when we compared the functionality 
of nitrated vs. no nitrated CD8+ T cells within the EM–EMRA 
populations (Figure S3 in Supplementary Material). These results 
indicated that nitrated cytotoxic T cells from chagasic patients were 
less functional than non-nitrated population. Moreover, chagasic 
patients showed a decreased percentage of CD39+ and CD73+ 
lymphocytes compared to control donors (Figure 4D). However, 
FigUre 4 | cytotoxic T cells from chagasic patients are less functional than those from healthy individuals. (a) Mean fluorescence intensity of 
TCRζ-chain in CD3+CD4+ and CD3+CD8+ cells; (B) frequency of CD107a+ cells, IFNγ, TNF, and IL-2-producing CD8+ T lymphocytes from chagasic patients 
(n = 5) and seronegative donors (n = 5) after PMA/ionomycin stimulation. (c) Frequency of CD107a+ cells, IFNγ, TNF, and IL-2-producing NT+ and NT− gated in 
CD8+ T lymphocytes from chagasic patients (n = 4) after anti-CD3+ anti-CD28 stimulation. (D) Percentage of CD39+ and CD73+ leukocytes from seropositive 
(n = 20) and seronegative (n = 14) individuals (*p < 0.05 and **p < 0.01).
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frequency of CD8+ T cells expressing Tim-3, PD-1, or CTLA-4 
was no different between chagasic patients and seronegative 
donors (Figure S4 in Supplementary Material). The results suggest 
that although cytotoxic T cells are less functional in seropositive 
subjects, they appear not to be a classically exhausted population 
since the expression of inhibitory receptors was not upregulated 
compared to CD8+ T cells from seronegative subjects.
il-1β Plasma levels Were increased in 
seropositive Patients
The cytokine plasma levels were assayed using a panel of capture 
beads. In seronegative and seropositive individuals, the levels of 
IL-6, IFNγ, TNF, and IL-4 were similar. However, IL-1β levels 
were higher, and the amount of IL-10 was lower in plasma from 
chagasic people compared with control donors (Figure 5).
FigUre 5 | il-1β plasma levels are higher in seropositive patients than in seronegative donors. Plasma levels of IL-6, IL-10, IFNγ, TNF, and IL-4  
(assayed by a panel of capture beads) and IL-1β (evaluated by enzyme-linked immunosorbent assay) in chagasic patients (n = 18) and non-chagasic donors 
(n = 15) (*p < 0.05).
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il-6 Prevented cD8+ T cell nitration and 
apoptosis susceptibility and Decreased 
il-1β Production by infected PBMcs
The IL-6 stimulation of in vitro-infected PBMCs obtained from 
healthy donors blunted T. cruzi-induced NT in CD3+CD8+ 
cells. Conversely, the treatment of these cultures with a neutral-
izing antibody specific for IL-6 (αIL-6) increased the percentage 
of T.  cruzi-induced NT in this subpopulation (Figure  6A). 
Moreover, IL-6 treatment rescued infected CD8+ T cells from 
apoptosis (Figure  6B). Concomitantly, while IL-6 stimulation 
diminished the levels of IL-1β in culture supernatants from 
T-cruzi-infected PBMCs, αIL-6 treatment increased the release 
of IL-1β (Figure 6C). Furthermore, although IL-6 stimulation did 
not affect NO production by T. cruzi-infected PBMCs, the block-
age of IL-6 significantly increased T. cruzi-induced NO produc-
tion (Figure 6D). Additionally, IL-6 stimulation diminished NT 
in infected CD3+CD8+ cells from peripheral blood of chagasic 
patients (Figure S5 in Supplementary Material). In accordance, 
we found that blocking IL-6 and IL-1β significantly diminished 
the percentage of NT+CD8+ T cells from in  vitro-infected 
PBMCs in comparison with cultures incubated with anti-IL-6 
alone (Figure 7A). Moreover, the percentage of NO-producing 
monocytes significantly diminished when both cytokines were 
blocked compared with the inhibition of IL-6 alone (Figure 7B).
DiscUssiOn
Multiple immunological effector mechanisms are critical for 
resolving T. cruzi infection, but considering that this parasite 
invades and replicates in essentially all types of mammalian cells, 
T cells and monocytes/macrophages are particularly important 
for controlling the infection. As with other intracellular parasites, 
T. cruzi antigens are processed and presented on MHC-class I 
molecules, leading to the recognition of parasite components 
by CD8+ T cells. In this regard, the study of the induction of 
CD8+ T cell-mediated protective immunity has become a center 
of intense research efforts to find control measures and prophy-
lactic tools that could be used to produce effective therapeutic 
vaccines. This study shows that chronic T. cruzi infection leads 
to a significant nitration of T lymphocytes, mainly of the CD8+ 
T cell subset. The increased tyrosine nitration was associated with 
impaired effector functions and a significant fall in the number 
and percentage of circulating CD8+ T cells in chronic Chagas 
patients.
Among the reactive oxygen and nitrogen species mediat-
ing T-cell suppression is peroxynitrite, one of the most potent 
oxidants in the body. The hyperproduction of peroxynitrite is 
associated with nitration of the surface proteins in T cells (11, 12). 
Regarding CD8+ T cells, nitration of tyrosines within the TCR/
CD8 complex disrupts the binding of the specific peptide-MHC 
dimers to CD8 molecules, which results in the inability of this 
T cell subset to bind MHC (18, 19). Furthermore, peroxynitrites 
also inhibit TCR signaling by preventing the association of CD3-
ζ with the TCR. Our group has reported that T. cruzi induces 
an increase in splenic NT+CD8+ and NT+CD4+ T cells from 
infected mice by performing confocal and flow cytometric 
analysis of immunofluorescence staining (13). In this work, we 
found that the increased nitration of CD8+ T cells was associ-
ated with a lower capacity for activation (TCRζ expression), a 
FigUre 6 | il-6 prevents nitration, increases survival of cD3+cD8+ cells, and decreases il-1β levels after infection. (a) Percentage of NT+CD3+CD8+ 
cells in infected peripheral blood mononuclear cells (PBMCs) from non-chagasic (n = 5) donors after 48 h of stimulation with IL-6 (Trypanosoma cruzi + IL-6) or αIL-6 
(T. cruzi + αIL-6) or medium alone (T. cruzi). (B) Percentage of viable CD3+CD8+ cells infected with T. cruzi (T. cruzi) or infected and stimulated with IL-6  
(T. cruzi + IL-6). (c) IL-1β levels and (D) nitric oxide levels in culture supernatants of infected PBMCs after 48 h of stimulation with IL-6 (T. cruzi + IL-6) or αIL-6  
(T. cruzi + αIL-6) or medium alone (T. cruzi) (*p < 0.05 and **p < 0.01).
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diminished production of cytokines (IFNγ, TNF, and IL-2) and 
deactivation of cytotoxic functions (CD107a expression) in this 
cell population. Strikingly, cellular nitration seems to be revers-
ible, since the incubation of infected leukocytes from seropositive 
patients with IL-6 significantly diminished the percentage of 
NT+ lymphocytes.
Leukocytes from chagasic patients significantly increased the 
production of NO, which correlated with increased susceptibility 
of CD8+ T cells to undergo spontaneous apoptosis. NO-mediated 
suppression of T-cell activation does not seem to be mediated 
by events triggered by TCR recognition but, instead, with the 
signaling cascade that is downstream of IL-2 (20). In human 
T cells, NO affects the stability of IL-2 mRNA and the release of 
IL-2. In this sense, NO negatively regulates intracellular signal-
ing proteins either directly, by S-nitrosylation of crucial cysteine 
residues, or indirectly, by activation of cyclic-GMP-dependent 
protein kinase (21). Furthermore, while NO also sensitizes cells 
to Fas-L-mediated apoptosis (22), the anti-apoptotic molecule 
Bcl-2 diminished the susceptibility to NO-induced apoptosis 
(23). In line with these reports, we found that CD8+ T cells 
from seropositive individuals showed a significantly decreased 
expression of Bcl-2 concomitant with the significant diminution 
in their viability. The increased susceptibility to apoptosis was 
in accordance with the diminution in the percentage as well as 
FigUre 7 | The blockage of il-6 and il-1β reverts the phenotype 
induced by anti-il-6. (a) Percentage of NT+CD8+ T cells and (B) 
NO-producing monocytes (CD14+) in in vitro-infected peripheral blood 
mononuclear cells from seronegative (n = 5) subjects after 48 h of stimulation 
with anti-IL-6 or anti-IL-6 + anti-IL-1β (*p < 0.05 and **p < 0.01).
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absolute number of total T cells at the expense of diminution of 
CD8+ T cells but not of T helper cells or B cells.
It was reported that NO levels, as measured by Griess reagent 
assay, were not significantly increased in the plasma of sero-
positive subjects compared with those in seronegative samples. 
However, the plasma level of 3-nitrotyrosine (NT), was increased 
in seropositive subjects (24). The results indicated that sero-
positive subjects with Chagas disease are exposed to increased 
nitrosative stress. In total agreement with this report, we observed 
no significant increase in plasma levels of nitrate/nitrite of 
seropositive subjects compared with seronegative donors. 
Nevertheless, the leukocytes from chagasic patients significantly 
increased the production of NO, suggesting that NO produced by 
leukocytes, rather than soluble NO, may contribute to increased 
nitrosative stress in patients with Chagas disease, evidencing 
the importance of cell-to-cell contact for NO inhibitory effec-
tor functions (25,  26). Although tyrosine nitration constitutes 
one of the mechanisms employed by MDSC to suppress T cell 
response through cell-to-cell contact, it may also be dependent 
on the activity of myeloperoxidase, secreted by monocytes and 
polymorphonuclear neutrophils (27).
In accordance with our recent observations, while IL-1β 
plasma levels were significantly increased in chagasic patients, 
the stimulation of in vitro-infected PBMCs with IL-6 significantly 
diminished the production of IL-1β. Moreover, IL-6 diminished 
the nitration rate and improved the survival of CD8+ T cells. In 
agreement with this result, we have previously shown that IL-6 
acts as a survival factor for infected target cells (28, 29). We have 
observed that IL-6 regulates IL-1β-induced NO production, and 
that excessive oxidative stress accounts for the increased mortal-
ity of T. cruzi-infected IL6KO mice (unpublished results). The 
anti-inflammatory action of IL-6 appears to be central to con-
trolling cardiac and systemic oxidative stress, promoting cellular 
rescue against apoptosis, and protecting infected IL-6-deficient 
mice against death. In this model, this was clearly illustrated by 
the fact that the percentage of nitrated CD8+ T cells observed 
after blocking IL-6 was significantly diminished when anti-IL-6 
was combined with anti-IL-1β. In accordance, IL-6 stimulation 
of peripheral blood cells from chagasic patients induced a signifi-
cant diminution of nitration of CD8+ T cells. Our results strongly 
suggest that IL-6 could represent a key factor for regulating the 
nitration of proteins on human cytotoxic T cells.
One potential regulatory system that could have a role in 
the IL-6-induced anti-inflammatory effects is the extracellular 
levels of adenosine. T. cruzi infection of cardiac tissue induces an 
influx of immune cells that consume large quantities of oxygen. 
Ischemic cells rapidly respond to the hypoxic and inflamma-
tory environment by releasing ATP (normally present within 
cardiomyocytes in millimolar concentrations). Once in the 
extracellular environment, ATP is converted to AMP and then 
to adenosine by the CD39 and CD73 ectoenzymes, respectively 
(30). In pathological conditions, high levels of ATP act as a pro-
inflammatory danger signal, activating the inflammasome that 
processes pro-IL-1β into mature IL-1β (31, 32). In this sense, 
it has been suggested that CD39 expression may contribute to 
dampening the ongoing inflammatory processes and/or rescue 
the cells from ATP-induced apoptosis/necrosis (33). Ultimately, 
adenosine exerts potent anti-inflammatory effects on different 
immune cell types. Recently, we reported that purinergic signal-
ing is clue in regulating the immune response to experimental 
T. cruzi infection. The temporal pharmacological inhibition of 
CD73 during the early acute phase of the infection induces micro-
bicidal mechanisms, with the concomitant reduction in cardiac 
parasite load, improving the outcome of chronic cardiomyopathy 
(34). In agreement with a previous report that indicated CD73 
expression on T cells is downregulated in chronic HIV infection 
(35), in this work, we observed lower expression of CD39 and 
CD73 on fresh explanted lymphocytes from chagasic patients 
compared to seronegative donor. Thus, it is plausible that the 
downregulation of ATP catabolic enzymes could be involved in 
the increased plasma IL-1β levels in chagasic patients.
In summary, the results of this study show that chronic 
T. cruzi infection leads to a decrease in the number and percent-
age of total circulating CD8+ T cells and that NO produced by 
leukocytes may contribute to lowering the effector function of 
these cells, which ultimately may results in an inefficient control 
of parasite replication. The findings also suggest that IL-6 could 
be a key factor to improve CD8+ T cell activation and survival.
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